RxSight, Inc. (RXST) News
Filter RXST News Items
RXST News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest RXST News From Around the Web
Below are the latest news stories about RXSIGHT INC that investors may wish to consider to help them evaluate RXST as an investment opportunity.
RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving AverageGood things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react? |
RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call TranscriptRxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript November 12, 2023 Operator: Good day, and thank you for standing by. Welcome to the RxSight Third Quarter 2023 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Alex […] |
Here's Why We're Not Too Worried About RxSight's (NASDAQ:RXST) Cash Burn SituationWe can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining... |
Q3 2023 Rxsight Inc Earnings CallQ3 2023 Rxsight Inc Earnings Call |
RxSight, Inc. Reports Third Quarter 2023 Financial ResultsALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three and nine months ended September 30, 2023. Key Quarterly Highlights Reported third quarter 2023 revenue of $22.2 million, an increase of 76% compared to the third quarter of 2022, reflecting: The sale of 66 Light Delivery Devices (LDD™s |
RxSight, Inc. Educational and Product Announcements for AAO 2023ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced educational opportunities and product updates at the American Academy of Ophthalmology (AAO) Annual Meeting on November 3 – 6 in San Francisco. These include three scientific poster presentations (PO005, PO457, PO050) and 15 booth presentations (booth #229). At th |
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the third quarter 2023 after the market close on Thursday, November 9, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Participan |
RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for InvestorsIs it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average? |
RxSight, Inc. to Present at the Wells Fargo Healthcare ConferenceALISO VIEJO, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference. RxSight’s management is scheduled to participate in a fireside chat on Wednesday, September 6, 2023, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Interested parties may access a live and archived webcast |
Has Alcon (ALC) Outpaced Other Medical Stocks This Year?Here is how Alcon (ALC) and RxSight, Inc. (RXST) have performed compared to their sector so far this year. |